PAK4 phosphorylates cyclin-dependent kinase 2 to promote the G1/S transition during adipogenesis

Hwang Chan Yu1, Su Hyeon Park1, Hye Jin Jo2

  • 1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

PubMed

Insights

p21-activated kinase 4 (PAK4) is crucial for adipocyte differentiation, impacting fat mass. This discovery highlights PAK4 as a potential therapeutic target for obesity treatment.

Area of Science:

  • Cell Biology
  • Metabolism
  • Molecular Biology

Background:

  • p21-activated kinase 4 (PAK4) is known for its role in tumor development.
  • Recent studies identified PAK4's involvement in triacylglycerol lipolysis in adipocytes.
  • PAK4's function in adipogenesis was previously unclear.

Purpose of the Study:

  • To investigate the role of PAK4 in adipocyte differentiation.
  • To elucidate the molecular mechanisms by which PAK4 regulates adipogenesis.
  • To assess the therapeutic potential of targeting PAK4 for obesity treatment.

Main Methods:

  • Studied PAK4 protein levels during adipogenic stimulation.
  • Utilized PAK4 knockdown in 3T3-L1 preadipocytes and human stromal vascular cells.
  • Employed pharmacological inhibition of PAK4 in 3T3-L1 cells.
  • Analyzed adipocyte marker gene expression and lipid accumulation.
  • Investigated PAK4's phosphorylation of cyclin-dependent kinase 2 (CDK2).
  • Examined fat mass and adipocyte size in preadipocyte-specific Pak4-knockout mice.

Main Results:

  • PAK4 protein levels increased following adipogenic stimulation.
  • PAK4 knockdown or inhibition impaired adipogenesis, reducing adipocyte marker gene expression and lipid accumulation.
  • PAK4 was found to phosphorylate CDK2 at serine 106, a key step for CCAAT/enhancer-binding protein β expression during mitotic clonal expansion.
  • Preadipocyte-specific Pak4-knockout mice showed reduced fat mass and smaller adipocytes.

Conclusions:

  • PAK4 plays a critical role in regulating adipocyte differentiation.
  • PAK4's function in promoting adipogenesis, alongside its inhibitory role in lipolysis, makes it a significant target for obesity therapeutics.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.5K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
134.3K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.3K